NCT06031831

Brief Summary

This hospital-based retrospective study reviewed patients who underwent surgery for CHD between 2017 and 2020 and analyzed the clinical features and outcomes associated with airway anomalies.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
999

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 15, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

September 4, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 11, 2023

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

September 11, 2023

Status Verified

May 1, 2023

Enrollment Period

8 months

First QC Date

September 4, 2023

Last Update Submit

September 4, 2023

Conditions

Congenital Heart DiseasePediatric

Outcome Measures

Primary Outcomes (2)

  • surgical mortality

    hospital expired after operation

    1 year

  • intermediate survival

    expired during follow-up

    5 years

Secondary Outcomes (2)

  • post-operative ICU stay

    1 year

  • post-operative intubated days

    1 year

Interventions

airway anomaliesOTHER

with or without airway anomalies

Eligibility Criteria

Age0 Days - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

All pediatric patients (age \<18 years) who underwent surgery for CHD at our hospital between January 1, 2017, and December 31, 2020

You may qualify if:

  • all pediatric patients (age \<18 years) who underwent surgery for CHD at our hospital between January 1, 2017, and December 31, 2020.

You may not qualify if:

  • with much missing clinical data

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jenghung Wu

Taipei, Taiwan R., 100229, Taiwan

Location

MeSH Terms

Conditions

Heart Defects, Congenital

Condition Hierarchy (Ancestors)

Cardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 4, 2023

First Posted

September 11, 2023

Study Start

May 15, 2022

Primary Completion

December 31, 2022

Study Completion

December 31, 2024

Last Updated

September 11, 2023

Record last verified: 2023-05

Locations

TW(1)